Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Astrana Health Q3 EPS $0.01 Misses $0.41 Estimate, Sales $956.048M Beat $952.789M Estimate

Author: Benzinga Newsdesk | November 06, 2025 04:12pm
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.41 by 97.54 percent. This is a 96.97 percent decrease over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $956.048 million which beat the analyst consensus estimate of $952.789 million by 0.34 percent. This is a 99.71 percent increase over sales of $478.710 million the same period last year.

Posted In: ASTH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist